The content is available as a PDF (399.3 KB).
Supplementary data
Transoesophageal echocardiography (TEE; RV inflow/outflow view) of the first patient showing tricuspid single leaflet device attachment (SLDA) on the posterior leaflet of the PASCAL device.
TEE (transgastric en face view) of the first patient during EVOQUE implantation showing the anchors capturing the PASCAL device.
Fluoroscopy of the first patient at the end of the procedure with the PASCAL and EVOQUE.
Final result (TEE, 3D with colour Doppler in systole) of the first patient after EVOQUE implantation.
TEE (transgastric en face view) of the second patient with torrential TR after SLDA of the PASCAL device on the septal leaflet.
TEE (transgastric en face view) of the second patient during EVOQUE implantation showing the deployment of the anterior anchors to capture the PASCAL device.
Fluoroscopy of the second patient at the end of the procedure.
Final result of the second patient after EVOQUE implantation.
Acknowledgments
Conflict of interest statement
J. Hausleiter declares support for research projects paid to the institution from Abbott Vascular and Edwards Lifesciences, and has received speaker honoraria from Abbott Vascular and Edwards Lifesciences. M. Näbauer has received speaker honoraria from Abbott Vascular. The other authors have no conflicts of interest to declare.
Contributor Information
Mirjam Wild, Medizinische Klinik und Poliklinik I, LMU Klinikum, Munich, Germany.
Firas Zahr, OHSU Knight Cardiovascular Institute Cardiology Clinic, Portland, OR, USA.
Michael Näbauer, Medizinische Klinik und Poliklinik I, LMU Klinikum, Munich, Germany.
Steffen Massberg, Medizinische Klinik und Poliklinik I, LMU Klinikum, Munich, Germany.
Jörg Hausleiter, Medizinische Klinik und Poliklinik I, LMU Klinikum, Munich, Germany.
References
- Fam NP, Moss R, Hahn RT, Leon MB, Peterson MD, Grayburn PA, Mack MJ, Deva DP, Ye J, Kreidel F, Schnitzler K, Bapat V, Ali FM, von Bardeleben RS, Nabauer M, Szerlip M, George I, Ruf T, Boone R, Ong G, Hausleiter J, Smith RL, Kodali SK, Hensey M, Webb JG. Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. JACC Cardiovasc Interv. 2021;14:501–11. doi: 10.1016/j.jcin.2020.11.045. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Transoesophageal echocardiography (TEE; RV inflow/outflow view) of the first patient showing tricuspid single leaflet device attachment (SLDA) on the posterior leaflet of the PASCAL device.
TEE (transgastric en face view) of the first patient during EVOQUE implantation showing the anchors capturing the PASCAL device.
Fluoroscopy of the first patient at the end of the procedure with the PASCAL and EVOQUE.
Final result (TEE, 3D with colour Doppler in systole) of the first patient after EVOQUE implantation.
TEE (transgastric en face view) of the second patient with torrential TR after SLDA of the PASCAL device on the septal leaflet.
TEE (transgastric en face view) of the second patient during EVOQUE implantation showing the deployment of the anterior anchors to capture the PASCAL device.
Fluoroscopy of the second patient at the end of the procedure.
Final result of the second patient after EVOQUE implantation.